Clinical Study

Economic Impact of Infected Total Knee Arthroplasty

Table 3

Cost analysis of infected TKA and the case control group with reimbursements from the G-DRGs in Euro (€).

GroupNumber of patientsMean cost per patientMean reimbursement (G-DRGs)Mean profit/lossCost coverage

Infected TKA2825,194€18,838€−6,356€74.77%
Case control group216,889€7,816€+927€111.86%